UCB SA (EBR:UCB)
136.30
-2.10 (-1.52%)
Apr 17, 2025, 5:35 PM CET
UCB SA Revenue
In the year 2024, UCB SA had annual revenue of 6.15B EUR with 18.72% growth. UCB SA had revenue of 3.36B in the half year ending December 31, 2024.
Revenue
6.15B
Revenue Growth
+18.72%
P/S Ratio
4.21
Revenue / Employee
667.61K
Employees
9,378
Market Cap
25.90B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 6.15B | 970.00M | 18.72% |
Dec 31, 2023 | 5.18B | -265.00M | -4.87% |
Dec 31, 2022 | 5.45B | -330.00M | -5.71% |
Dec 31, 2021 | 5.78B | 430.00M | 8.04% |
Dec 31, 2020 | 5.35B | 434.00M | 8.83% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
argenx SE | 2.17B |
Financière de Tubize | 13.26K |
Fagron NV | 871.96M |
Ion Beam Applications | 465.75M |
Nyxoah | 4.52M |
Hyloris Pharmaceuticals | 10.04M |
Onward Medical | 1.70M |
Sequana Medical NV | 433.50K |
UCB SA News
- 6 weeks ago - Europe-Based UCB's Bimzelx Data Reveals Sustained Skin Clearance In Inflammatory Skin Disorders - Benzinga
- 6 weeks ago - BIMZELX® (bimekizumab-bkzx) Two-Year Data at AAD Showed Potential to Eliminate Draining Tunnels in Hidradenitis Suppurativa, and Reduction in Disease Burden - Benzinga
- 6 weeks ago - UCB SA (UCBJF) (Q4 2024) Earnings Call Highlights: Strong Revenue Growth and Strategic ... - GuruFocus
- 6 weeks ago - Full Year 2024 Ucb SA Earnings Call Transcript - GuruFocus
- 7 weeks ago - Decoding United Community Banks Inc (UCB): A Strategic SWOT Insight - GuruFocus
- 3 months ago - United Community Banks, Inc. (UCB) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - United Community Banks Non-GAAP EPS of $0.63 beats by $0.07, revenue of $239.47M misses by $3.26M - Seeking Alpha
- 3 months ago - UCB Announces U.S. Availability of 320 mg/2 mL Single-Injection Administration Option for BIMZELX® (bimekizumab-bkzx) - Benzinga